Published in Circ Res on September 17, 2004
Vascular Calcification's Risk Factors in Haemodialysis Patients | NCT00694824
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest (2005) 3.00
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int (2009) 2.60
Survival in patients with poorly compressible leg arteries. J Am Coll Cardiol (2012) 2.25
Regulatory mechanisms in vascular calcification. Nat Rev Cardiol (2010) 2.22
Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol (2009) 2.09
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int (2013) 1.90
Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol (2008) 1.85
Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol (2005) 1.59
Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids Health Dis (2016) 1.44
Vascular calcification in chronic kidney disease. J Bone Miner Metab (2006) 1.42
High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity. PLoS One (2016) 1.38
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35
Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res (2008) 1.22
Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant (2011) 1.20
Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun (2008) 1.15
Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant (2012) 1.10
Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep (2012) 1.06
Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01
Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J (2012) 1.00
Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence (2013) 0.99
Clinical, cellular, and molecular aspects of arterial calcification. J Vasc Surg (2007) 0.96
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv (2014) 0.94
Arterial stiffness. JRSM Cardiovasc Dis (2012) 0.93
Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha. Proc Natl Acad Sci U S A (2008) 0.93
Gla-rich protein is a novel vitamin K-dependent protein present in serum that accumulates at sites of pathological calcifications. Am J Pathol (2009) 0.93
Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol (2008) 0.92
Mechanisms of ectopic calcification: implications for diabetic vasculopathy. Cardiovasc Diagn Ther (2015) 0.89
The role of bone biopsy in patients with chronic renal failure. Clin J Am Soc Nephrol (2008) 0.89
Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients. Heart Vessels (2011) 0.89
Calcification in the ovine intervertebral disc: a model of hydroxyapatite deposition disease. Eur Spine J (2009) 0.87
Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities. Proc Natl Acad Sci U S A (2007) 0.87
Protective roles of DMP1 in high phosphate homeostasis. PLoS One (2012) 0.86
The connections between vascular calcification and bone health. Nephrol Dial Transplant (2011) 0.85
Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies. EBioMedicine (2016) 0.85
Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis (2014) 0.84
Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1. PLoS One (2013) 0.84
Vascular calcification in end-stage renal disease. Hemodial Int (2013) 0.84
Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm (2014) 0.83
Regulatory circuits controlling vascular cell calcification. Cell Mol Life Sci (2012) 0.83
Fluctuating plasma phosphorus level by changes in dietary phosphorus intake induces endothelial dysfunction. J Clin Biochem Nutr (2014) 0.82
Effect of high glucose levels on the calcification of vascular smooth muscle cells by inducing osteoblastic differentiation and intracellular calcium deposition via BMP-2/Cbfα-1 pathway. J Zhejiang Univ Sci B (2010) 0.82
Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease. J Cardiovasc Transl Res (2012) 0.82
Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium. PLoS One (2015) 0.82
IL-10 genetic polymorphisms were associated with valvular calcification in Han, Uygur and Kazak populations in Xinjiang, China. PLoS One (2015) 0.81
Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients. Clin Kidney J (2014) 0.81
NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency. J Am Soc Nephrol (2015) 0.81
Magnesium prevents β-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells. Biomed Rep (2015) 0.81
Pathophysiology of the chronic kidney disease-mineral bone disorder. Curr Opin Nephrol Hypertens (2015) 0.80
Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. J Ren Nutr (2007) 0.80
Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients. Int J Endocrinol (2015) 0.80
Enhanced mineralization potential of vascular cells from SM22α-Rankl (tg) mice. Calcif Tissue Int (2012) 0.79
The Role of Shear Stress in Arteriovenous Fistula Maturation and Failure: A Systematic Review. PLoS One (2015) 0.79
Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients. BMC Nephrol (2014) 0.79
Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis (2013) 0.79
Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. PLoS One (2013) 0.79
Pyruvate Dehydrogenase Kinase 4 Promotes Vascular Calcification via SMAD1/5/8 Phosphorylation. Sci Rep (2015) 0.79
Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patients. Clin Exp Nephrol (2013) 0.79
Vascular calcification: When should we interfere in chronic kidney disease patients and how? World J Nephrol (2016) 0.78
Advanced glycation end products promote human aortic smooth muscle cell calcification in vitro via activating NF-κB and down-regulating IGF1R expression. Acta Pharmacol Sin (2013) 0.78
The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Transplantation (2016) 0.78
Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Med Sci Monit (2014) 0.78
Use of magnesium as a drug in chronic kidney disease. Clin Kidney J (2012) 0.77
5(th) Asian PAD Workshop. Ann Vasc Dis (2014) 0.77
Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives. Clin Exp Nephrol (2012) 0.77
Five-sixth Nephrectomy in Female Common Marmosets(Callithrix jacchus) as a Chronic Renal Failure Model: -A Longitudinal Course of Serum Biochemical, Hematological and Histopathological Changes-. J Toxicol Pathol (2014) 0.76
Endothelin but Not Angiotensin II May Mediate Hypertension-Induced Coronary Vascular Calcification in Chronic Kidney Disease. Int J Nephrol (2011) 0.76
Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney Disease. PLoS One (2015) 0.76
MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. J Am Soc Nephrol (2015) 0.76
Experimental models of renal disease and the cardiovascular system. Open Cardiovasc Med J (2010) 0.76
Clinical assessment of atherosclerotic parameters and cardiac function in chronic hemodialysis patients. Clin Exp Nephrol (2009) 0.75
Bone marrow blood vessel ossification and "microvascular dead space" in rat and human long bone. Bone (2014) 0.75
Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys. Pulse (Basel) (2016) 0.75
Carotid intima-media thickness as a marker of atherosclerosis in hemodialysis patients. Indian J Nephrol (2016) 0.75
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel) (2016) 0.75
Pre-treatment considerations in childhood hypertension due to chronic kidney disease. World J Nephrol (2015) 0.75
Baroreflex dysfunction in chronic kidney disease. World J Nephrol (2016) 0.75
Uremic toxins are conditional danger- or homeostasis-associated molecular patterns. Front Biosci (Landmark Ed) (2018) 0.75
Soy protein diet and exercise training increase relative bone volume and enhance bone microarchitecture in a mouse model of uremia. J Bone Miner Metab (2011) 0.75
End Stage Renal Disease-induced Hypercalcemia May Promote Aortic Valve Calcification via Annexin VI Enrichment of Valve Interstitial Cell Derived-Matrix Vesicles. J Cell Physiol (2017) 0.75
Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study. PLoS One (2017) 0.75
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int (2002) 2.03
Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol (2007) 1.93
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int (2005) 1.77
Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol (2009) 1.58
Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int (2003) 1.52
A rat model of chronic kidney disease-mineral bone disorder. Kidney Int (2008) 1.45
The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J Bone Miner Res (2011) 1.18
Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol (2003) 1.11
Inflammation and vascular calcification. Blood Purif (2005) 1.00
A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res (2014) 0.98
R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD). Nephrol Dial Transplant (2009) 0.98
Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res (2015) 0.95
Development of progressive aortic vasculopathy in a rat model of aging. Am J Physiol Heart Circ Physiol (2007) 0.92
Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment. Am J Nephrol (2013) 0.78
[Vascular calcification in end stage renal disease]. Clin Calcium (2002) 0.76
Identity and localization of advanced glycation end products on human beta2-microglobulin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem (2003) 0.76
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease. Am J Nephrol (2016) 0.75
Cellular uptake of beta2M and AGE-beta2M in synovial fibroblasts and macrophages. Nephrol Dial Transplant (2003) 0.75